Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Colorcon
McKesson
Medtronic
Express Scripts

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for L-Citrulline

See Plans and Pricing

« Back to Dashboard

Drug Development Status for L-Citrulline: Patents, clinical trial progress, indications

L-Citrulline is an investigational drug.

There have been 18 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2016.

The most common disease conditions in clinical trials are Syndrome, Anemia, Sickle Cell, and Muscular Dystrophy, Duchenne. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, Masih Daneshvari Hospital, and Angiogenix.

There are nine hundred and seventy-three US patents protecting this investigational drug and twelve international patents.

Recent Clinical Trials for L-Citrulline
TitleSponsorPhase
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Institutes of Health (NIH)Phase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesUniversity of Colorado, DenverPhase 2

See all L-Citrulline clinical trials

Clinical Trial Summary for L-Citrulline

Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline

See all L-Citrulline clinical trials

US Patents for L-Citrulline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Citrulline   Start Trial Template-fixed peptidomimetics POLYPHOR LTD. (Allschwil, CH)   Start Trial
L-Citrulline   Start Trial Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA)   Start Trial
L-Citrulline   Start Trial Anti-FGFR3 antibodies and methods using same Genentech, Inc. (South San Francisco, CA)   Start Trial
L-Citrulline   Start Trial Bispecific antigen-binding constructs targeting HER2 Zymeworks Inc. (Vancouver, CA)   Start Trial
L-Citrulline   Start Trial Methods of expressing products in mammalian cells INTREXON CEU, INC. (Blacksburg, VA)   Start Trial
L-Citrulline   Start Trial Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for L-Citrulline

Drugname Country Document Number Estimated Expiration Related US Patent
L-Citrulline Australia 2007345497 2027-01-29   Start Trial
L-Citrulline Canada 2676865 2027-01-29   Start Trial
L-Citrulline European Patent Office 2114986 2027-01-29   Start Trial
L-Citrulline Spain 2425575 2027-01-29   Start Trial
L-Citrulline World Intellectual Property Organization (WIPO) 2008092281 2027-01-29   Start Trial
L-Citrulline Australia 2006269422 2025-07-07   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Harvard Business School
Johnson and Johnson
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.